Alimentiv Employee Directory

Alimentiv is a global contract research organization (CRO) providing clinical trials, central image management, precision medicine and real world evidence services to the pharmaceutical and biotechnology industries. Headquartered in London, Ontario, Alimentiv employs more than 450 people across its operations in Canada, the United States, Europe, A... sia-Pacific, and Latin America. The unique model of the organization combines the efforts of internationally recognized academic researchers and operational experts to offer integrated solutions to customers. Founded in 1986 at the Robarts Research Institute, the clinical trials division was initially led by Dr. Henry Barnett. In 1997, Dr. Brian Feagan, Professor of Medicine, Epidemiology & Biostatistics at Western University assumed leadership and built upon the foundation of academic excellence by focusing the organization on Inflammatory Bowel Disease (IBD) research. Over the past 20 years, Alimentiv has become a recognized expert in clinical trial design, central image management solutions, outcome measure development, and precision medicine for drug development in IBD. Today, Alimentiv provides services in more than 50 countries worldwide, collaborates with leading universities and academic institutions across the globe, and partners with many of the leading pharmaceutical and biotechnology organizations to bring new and improved treatment options to patients. Alimentiv is committed to medical research and development, with a focus on identifying barriers to drug development and pursuing solutions that advance IBD research. The research findings are operationalized into efficient clinical trial methodology for clients that is in-line with emerging regulatory standards. In collaboration with leading experts, Alimentiv has pioneered the development, validation, and standardization of the outcome measures and technology that are shaping the evolving clinical trial landscape for multiple indications and providing meaningful long-term consequences for patients, ...Read More